Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ramat Gan, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Galmed Pharmaceuticals Ltd. has filed 364 SEC EDGAR filings since 31 Dec 2013

SEC filing history

Showing 151-175 of 364 matching filings.

Per page
25
Current page
7
6-K File 001-36345

6-K filing

Filing date
17 Jun 2022
Reporting date
17 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-36345

20-F filing

Filing date
02 May 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
02 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
28 Apr 2022
Reporting date
28 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
03 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88495

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88495

SC 13G/A filing

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88495

SC 13G/A

Filing date
27 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
11 Jan 2022
Reporting date
11 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
10 Jan 2022
Reporting date
10 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
08 Nov 2021
Reporting date
08 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
01 Nov 2021
Reporting date
01 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
12 Oct 2021
Reporting date
12 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
31 Aug 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
23 Aug 2021
Reporting date
23 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
19 Aug 2021
Reporting date
19 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
16 Aug 2021
Reporting date
16 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
19 Jul 2021
Reporting date
19 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
02 Jul 2021
Reporting date
02 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K filing

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .